Skip to main content
PASGHealthcare

Passage Bio Inc (PASG) Insider Trading

In the last 90 days, no Passage Bio Inc (PASG) insiders reported open-market purchases or sales on SEC Form 4.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 25, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 25, 2026Weston NicholsCorporate insiderOpen Market Purchase50,055$4.12$206,101
Jun 25, 2026Lynx1 Capital Management LPCorporate insiderOpen Market Purchase50,055$4.12$206,101

Common questions

PASG insider trading FAQ

Are PASG insiders buying or selling?
No PASG insiders reported open-market purchases or sales in the last 90 days.
When was the last PASG insider purchase?
No open-market insider purchase of Passage Bio Inc stock was reported in the last 90 days.
Where does PASG insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Passage Bio Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.